Dental Pain, Sensation Disorders
Conditions
Keywords
Tooth Extraction, Molar, Third, Meloxicam, Ibuprofen
Brief summary
Third molar extraction is a common dental procedure, offently related with pain and swelling. The purpose of this study is to evaluate if Meloxicam has a better effect relieving pain after the extraction than Ibuprofen, one of the most common pain relieving drugs administered after this procedure.
Detailed description
Summary: Third molar extractions are one of the most common procedures in dental practice. However, pain and swelling as postoperative sequelae are inevitable. Depending on the level of pain, which can range from moderate to severe, this symptomatology can be accompanied with pharmacological treatment, thus generating a less traumatic recovery for the patient. It is currently known that non-steroidal anti-inflammatory drugs (NSAIDs) have proven to be effective for the treatment of mild and moderate postoperative pain. Due to the wide variety of NSAIDs, it is important to know how to choose the most effective option when indicating one therapeutic option over another. Objective: To evaluate the postoperative analgesic effectiveness of meloxicam (7.5 mg) compared to ibuprofen (400 mg) in patients undergoing third molar(s) extraction. Design: Randomized controlled clinical trial, double-masked, designed according to CONSORT guideline requirements.
Interventions
DRUGmeloxicam 7,5mg
Comparison of analgesic efficacy of Meloxicam Vs Ibuprofen
Sponsors
Universidad Austral de Chile
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)
Eligibility
Sex/Gender
ALL
Age
18 Years to 59 Years
Healthy volunteers
Yes
Inclusion criteria
Maxillary or mandibular third molar with semi or fully erupted crown.
Exclusion criteria
Patients with Systemic pathologies. Presence of third molar localized infection. Completely included third molar crown. Periodontal compromise. Pregnant or breastfeeding women. Patients with hypersensitivity to NSAIDs. Patients with a history of drug abuse. Patients who had taken any drug in the previous 24 hours. Intervention (exodontia) time longer than 45 minutes.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Meloxicam effectiveness for post-surgical pain control. | 3 days | A visual analogue scale ranging from 0 points (no pain) to 10 points (intolerable pain) will be used to measure post-exodontic pain, and values will be recorded on a questionnaire. |
Contacts
Primary ContactCarla C Bertran, DDS
Backup ContactRuth R Falcón
Outcome results
None listed